ResearcherWuhan UniversityActive in the last 2 years
Kongfan Zhu
Matched on ORCID iD 0009-0000-3461-8405; OpenAlex author ID A5077329845. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 3
- UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach. Co-author DOI 10.17305/bb.2025.11958↗
- The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. Co-author DOI 10.1016/j.intimp.2023.110505↗
- Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling. Co-author DOI 10.1186/s13046-018-0972-3↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hanjun Li · 1 shared paper, 2025 · strength 0.33
- Weimin Hu · 1 shared paper, 2023 · strength 0.19
- Jian Chang · 1 shared paper, 2023 · strength 0.19
- Zhi‐Gang Tang · 1 shared paper, 2018 · strength 0.09
- Zhengle Zhang · 1 shared paper, 2018 · strength 0.09
- Jing Tao · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.